DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Loibl S, von Minckwitz G, Schneeweiss A et al.
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer.

J Clin Oncol 2014;
32: 3212-3220

Download Bibliographical Data

Search in:
Access: